Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Entao Li"'
Autor:
Shen Wang, Wujian Li, Zhenshan Wang, Wanying Yang, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-68 (2024)
Abstract To adequately prepare for potential hazards caused by emerging and reemerging infectious diseases, the WHO has issued a list of high-priority pathogens that are likely to cause future outbreaks and for which research and development (R&D) ef
Externí odkaz:
https://doaj.org/article/e56990ff0f50400e8208410920d55411
Autor:
Pengfei Fan, Mengmeng Sun, Xinghai Zhang, Huajun Zhang, Yujiao Liu, Yanfeng Yao, Ming Li, Ting Fang, Bingjie Sun, Zhengshan Chen, Xiangyang Chi, Li Chen, Cheng Peng, Zhen Chen, Guanying Zhang, Yi Ren, Zixuan Liu, Yaohui Li, Jianmin Li, Entao Li, Wuxiang Guan, Shanshan Li, Rui Gong, Kaiming Zhang, Changming Yu, Sandra Chiu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract The Hendra and Nipah viruses (HNVs) are highly pathogenic pathogens without approved interventions for human use. In addition, the interaction pattern between the attachment (G) and fusion (F) glycoproteins required for virus entry remains u
Externí odkaz:
https://doaj.org/article/14e8c25791854095a7cb85b5e6910684
Autor:
Li Chen, Mengmeng Sun, Huajun Zhang, Xinghai Zhang, Yanfeng Yao, Ming Li, Kangyin Li, Pengfei Fan, Haiwei Zhang, Ye Qin, Zhe Zhang, Entao Li, Zhen Chen, Wuxiang Guan, Shanshan Li, Changming Yu, Kaiming Zhang, Rui Gong, Sandra Chiu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Nipah virus (NiV) is a World Health Organization priority pathogen and there are currently no approved drugs for clinical immunotherapy. Through the use of a naïve human phage-displayed Fab library, two neutralizing antibodies (NiV41 and Ni
Externí odkaz:
https://doaj.org/article/8960ea1cd51c4e3a95f8fabca3b7e65c
Autor:
Zhenfei Wang, Weiyang Sun, Dongxu Li, Yue Sun, Menghan Zhu, Wenqi Wang, Yiming Zhang, Entao Li, Feihu Yan, Tiecheng Wang, Na Feng, Songtao Yang, Xianzhu Xia, Yuwei Gao
Publikováno v:
Virus Research, Vol 345, Iss , Pp 199378- (2024)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a significant threat to human health globally. It is crucial to develop a vaccine to reduce the effect of the virus on public health, economy, and society and regulate the transmissio
Externí odkaz:
https://doaj.org/article/476920871219488a986eff7604551418
Autor:
Tianxi Ye, Jinge Zhou, Chen Guo, Kaiyue Zhang, Yuping Wang, Yanhui Liu, Junhui Zhou, Yalin Xie, Entao Li, Rui Gong, Jiancun Zhang, Xia Chuai, Sandra Chiu
Publikováno v:
Cell Reports, Vol 43, Iss 6, Pp 114269- (2024)
Summary: The 2022 mpox outbreak led the World Health Organization (WHO) to declare it a public health emergency of international concern (PHEIC). There is a need to develop more effective and safer mpox virus (MPXV)-specific vaccines in response to t
Externí odkaz:
https://doaj.org/article/ff40d66c91494b0796b5f583f220ead0
Autor:
Mingqing Lu, Yanfeng Yao, Xuekai Zhang, Hang Liu, Ge Gao, Yun Peng, Miaoyu Chen, Jiaxuan Zhao, XiaoYu Zhang, Chunhong Yin, Weiwei Guo, Peipei Yang, Xue Hu, Juhong Rao, Entao Li, Tong Chen, Sandra Chiu, Gary Wong, Zhiming Yuan, Jiaming Lan, Chao Shan
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-12 (2023)
Abstract Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus that poses a severe threat to humans due to its high morbidity and the lack of viable countermeasures. Vaccines are the most crucial defense against NiV infections. Here, a recombin
Externí odkaz:
https://doaj.org/article/c88d19fdeeaa4602864f28c42221f13f
Autor:
Entao Li, Xiaoping Guo, Dongxiang Hong, Qizan Gong, Wenyu Xie, Tingting Li, Jian Wang, Xia Chuai, Sandra Chiu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract The ongoing pandemic caused by mpox virus (MPXV) has become an international public health emergency that poses a significant threat to global health. The vaccinia virus Tiantan strain (VTT) was used to vaccinate against smallpox in China 42
Externí odkaz:
https://doaj.org/article/cde1b175046a4759a25a8edc5ef73eaa
Autor:
Yi Wu, Namei Wu, Xiaoying Jia, Yan Wu, Xinghai Zhang, Yang Liu, Yuxia Hou, Yanqiong Shen, Entao Li, Wei Wang, Yucai Wang, Sandra Chiu
Publikováno v:
MedComm, Vol 4, Iss 6, Pp n/a-n/a (2023)
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron and its subvariants (such as BQ.1, XBB and the latest variants, including XBB.1.16, EG.5, and BA.2.86), as the dominant variants, currently account for almost all new i
Externí odkaz:
https://doaj.org/article/8091673580c04e849cdcf6e2f823203c
Autor:
Tian Qin, Beilei Shen, Entao Li, Song Jin, Rongbo Luo, Yiming Zhang, Jing Qi, Xiuwen Deng, Zhuangzhuang Shi, Tiecheng Wang, Yifa Zhou, Yuwei Gao
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes non-symptomatic infection, mild influenza-like symptoms to pneumonia, severe acute respiratory distress syndrome, and even death, reflecting different clinica
Externí odkaz:
https://doaj.org/article/8749c3b340654162a7801fffe9d7abe4
Autor:
Ningning Wang, Entao Li, Huifang Deng, Lanxin Yue, Lei Zhou, Rina Su, Baokun He, Chengcai Lai, Gaofu Li, Yuwei Gao, Wei Zhou, Yue Gao
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 13, Iss 1, Pp 11-23 (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced cytokine storms constitute the primary cause of coronavirus disease 19 (COVID-19) progression, severity, criticality, and death. Glucocorticoid and anti-cytokine therapies are frequ
Externí odkaz:
https://doaj.org/article/431fac8d88d94b72b587dba4dfded26f